Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Q4 2021 Autolus Therapeutics PLC Earnings Call Transcript

Mar 10, 2022 / 01:30PM GMT
Release Date Price: $3.94 (+2.60%)
Operator

Good day, and thank you for standing by, and welcome to Autolus Therapeutics Fourth Quarter 2021 Financial Results Conference Call. (Operator Instructions)

Please be advised, the call is being recorded. (Operator Instructions)

I would now like to hand the conference over to your host today, Lucinda Crabtree, Senior Vice President, Finance. You may begin.

Lucinda Crabtree
Autolus Therapeutics plc - SVP of Finance

Thank you, Justin. Good morning or good afternoon, everyone, and thank you for joining us to take part in today's call on the financial results and operational highlights for the fourth quarter 2021. I am Lucinda Crabtree, Senior Vice President of Finance. With me today are Dr. Christian Itin, our Chief Executive Officer; and Andrew Oakley, our Chief Financial Officer.

Before we begin, I would like to remind you that during today's call, our discussion will contain forward-looking statements. All statements other than statements of historical facts on this call are forward-looking statements. Actual results may differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot